Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Obese women with PCOS are more likely to have fatty liver disease.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Finasteride reduces hair growth and is safe for women with excessive hair.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Women with PCOS have more emotional and body image issues than healthy women.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Metformin helped improve the quality of life for Chinese women with PCOS, especially in physical health and symptoms like infertility, acne, and hair loss.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Women with PCOS have higher levels of a certain growth factor, which can be reduced by taking metformin.